Stockreport

Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris

Avinger, Inc.  (AVGR) 
Last avinger, inc. earnings: 8/8 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.avinger.com
PDF REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), [Read more]